[Oxidative stress in focal symptomatic and cryptogenic epilepsy in young patients]

A I Fedin1, E V Starykh1, O A Baranova1

  • 1Pirogov Russian National Research Medical University, Moscow, Russia.

Insights

Oxidative stress impacts epilepsy patients, with decreased antioxidant defense observed even after initial seizures. These changes persist across different epilepsy types, indicating ongoing free-radical process alterations.

Area of Science:

  • Neurology
  • Biochemistry
  • Oxidative Stress Research

Background:

  • Epilepsy is a chronic neurological disorder characterized by recurrent seizures.
  • Oxidative stress, an imbalance between free radicals and antioxidants, is implicated in various diseases.
  • Understanding oxidative stress in epilepsy is crucial for potential therapeutic strategies.

Purpose of the Study:

  • To investigate oxidative stress markers in young epilepsy patients with focal symptomatic and cryptogenic epilepsy.
  • To assess oxidative stress levels in relation to seizure onset, remission, and treatment resistance.
  • To evaluate pro-oxidant and antioxidant status in epilepsy patients compared to healthy controls.

Main Methods:

  • Studied 90 epilepsy patients (19-44 years) divided into three groups: first seizures, clinical remission, and treatment-resistant epilepsy.
  • Included a control group of 20 healthy individuals.
  • Measured plasma levels of TBA-reactive products (pro-oxidant) and antioxidant markers including superoxide-scavenging activity, catalase, total antioxidant activity, and reduced thiols (SH groups).

Main Results:

  • No significant difference in TBA-reactive products between epilepsy patients and controls.
  • Significantly decreased levels of reduced SH groups, total superoxide-scavenging activity, catalase activity, and total antioxidant activity in epilepsy patients.
  • Significant differences in antioxidant defense parameters were observed among the different patient groups.

Conclusions:

  • Oxidative stress-related changes, particularly in antioxidant defense, are evident in epilepsy patients even after the first seizures.
  • These alterations persist in treatment-resistant epilepsy and during clinical remission.
  • The findings suggest distinct oxidative stress profiles associated with different stages and types of epilepsy.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
497
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.1K
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
758